Patterns of care in renal cell carcinoma (RCC): Impact of duration of first-line (1L) treatment on second-line (2L) treatment choice. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting ...
Verywell Health on MSN
Diastolic Dysfunction: Everything You Need to Know
Diastolic dysfunction is a heart condition that happens when there is a “stiffening” of the major pumping chambers of the ...
Diastolic dysfunction increasingly is recognized as an important cause of congestive heart failure (CHF). In this study, Mayo Clinic researchers surveyed a random sample of 2042 adults (age, 45 or ...
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced initial dosing in a Phase 1 trial of EDG-7500.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback